Exposure–Response Relationship of T-DM1: Insight Into Dose Optimization for Patients With HER2-Positive Metastatic Breast Cancer
J Wang(United States Food and Drug Administration), Atiqur Rahman(Jamia Millia Islamia), Amna Ibrahim(Beni-Suef University), Nitin Mehrotra(Center for Drug Evaluation and Research), Gideon M. Blumenthal(Merck & Co., Inc., Rahway, NJ, USA (United States)), Robert Justice(United States Food and Drug Administration), Shenghui Tang(United States Food and Drug Administration), L. Amiri Kordestani(United States Food and Drug Administration), Sarah J. Schrieber(Center for Drug Evaluation and Research), Q Liu(United States Food and Drug Administration), Pengfei Song(Nanyang Technological University), Patricia Cortazar(Center for Drug Evaluation and Research), Qiang Xu(Wannan Medical College), B Booth(United States Food and Drug Administration), Y Wang(Lawrence Berkeley National Laboratory)
Cited by 65